Stock 301207 HUALAN BIOLOGICAL VACCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hualan Biological Vaccine Inc.

Equities

301207

CNE1000058J9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
21.28 CNY -8.87% Intraday chart for Hualan Biological Vaccine Inc. -6.13% -23.45%
Apr. 25 Hualan Biological Vaccine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 29 Hualan Biological Vaccine Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hualan Biological Vaccine Inc, formerly Hualan Biological Bacterin Inc, is a China-based company principally engaged in the research, development, production and sales of human vaccines. The Company's listed products mainly include influenza virus split vaccine, quadrivalent influenza virus split vaccine, influenza A H1N1 split vaccine, recombinant hepatitis B vaccine and others. The Company's products that have been approved for clinical trials or have passed clinical registration and are pending for marketing mainly include human rabies vaccines, adsorbed tetanus vaccines, H7N9 influenza whole virus inactivated vaccines and others. The Company's products in the preclinical research stage include inactivated new coronavirus vaccine, freeze-dried nasal spray recombinant new coronavirus live attenuated vaccine and others.

Number of employees: 770

Sales per Business

CNY in Million2022Weight2023Weight Delta
Influenza Vaccine
99.7 %
1,818 99.6 % 2,403 99.7 % +32.19%
Other
0.3 %
8 0.4 % 8 0.3 % -3.97%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.8 %
1,825 100.0 % 2,407 99.8 % +31.84%
Foreign
0.2 %
0 0.0 % 4 0.2 % +1,737.78%

Managers

Managers TitleAgeSince
Wen Jue An CEO
 Chief Executive Officer 35 22-03-28
Cheng Yu Lü DFI
 Director of Finance/CFO 43 20-05-31
Xiao Feng Cui CTO
 Chief Tech/Sci/R&D Officer 49 17-03-31
Ruo Wen Pan BRD
 Director/Board Member 56 13-05-31
Lun Li IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Kang An CHM
 Chairman 75 13-03-31
Bei Fan BRD
 Director/Board Member 52 13-03-31
Ruo Wen Pan BRD
 Director/Board Member 56 13-05-31
De Xin Li BRD
 Director/Board Member 71 20-05-31
Xiao Wei Ma BRD
 Director/Board Member 56 13-03-31
Dong Sheng Yang BRD
 Director/Board Member 60 20-05-31
Chao Yuan Ma BRD
 Director/Board Member 40 20-05-31
Wen Qi An BRD
 Director/Board Member 45 20-05-31
Yuan Cheng Lou CHM
 Chairman 40 20-05-31
Xin Lei Hu BRD
 Director/Board Member 35 23-06-25

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 600,015,000 83,163,286 ( 13.86 %) 0 13.86 %

Shareholders

NameEquities%Valuation
Hai Yan Zhang
26.07 %
36,767,850 26.07 % 121 M ¥
Zhuhai Gaoling Equity Investment Management Co. Ltd.
25.92 %
36,544,129 25.92 % 121 M ¥
Chenyi Investment Co. Ltd.
22.98 %
32,400,000 22.98 % 107 M ¥
Huatai Hualan Vaccine Home No 1 Gem Esop Asset Mgmt Plan
4.256 %
6,001,500 4.256 % 20 M ¥
Caitong Securities Asset Management Co., Ltd.
1.950 %
2,749,785 1.950 % 9 M ¥
China Merchants Fund Management Co., Ltd.
1.048 %
1,477,437 1.048 % 5 M ¥
Zhong Ge Kan
0.8374 %
1,180,814 0.8374 % 4 M ¥
Tian Hong Asset Management Co., Ltd.
0.8116 %
1,144,524 0.8116 % 4 M ¥
Franklin Templeton Sealand Fund Management Co., Ltd.
0.8089 %
1,140,594 0.8089 % 4 M ¥
Huatai Insurance Group Co., Ltd.
0.6386 %
900,470 0.6386 % 3 M ¥

Company contact information

Hualan Biological Vaccine, Inc.

No. 1, No. 1, Hualan Avenue

453003, Xinxiang

+

http://www.hualanbacterin.com
address Hualan Biological Vaccine Inc.(301207)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Hualan Biological Vaccine Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
21.28 CNY
Average target price
33.2 CNY
Spread / Average Target
+56.02%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
HUALAN BIOLOGICAL VACCINE INC. Stock Hualan Biological Vaccine Inc.
-23.45% 1.76B
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 301207 Stock
  4. Company Hualan Biological Vaccine Inc.